Quarterly report · Q2

Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 52
MetricValuePeriodScopeSource row
Operating income¥6.3bn2022-01-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥3.8bn2022-04-01 → 2022-06-30dCons.Operating profit loss IFRS
Operating income¥10.9bn2021-01-01 → 2021-06-30Cons.Operating profit loss IFRS
Operating income¥5.5bn2021-04-01 → 2021-06-30dCons.Operating profit loss IFRS
Profit before tax¥9.5bn2022-01-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥6.0bn2022-04-01 → 2022-06-30dCons.Profit loss before tax IFRS
Profit before tax¥19.5bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥12.2bn2021-01-01 → 2021-06-30Cons.Profit loss before tax IFRS
Profit before tax¥6.0bn2021-04-01 → 2021-06-30dCons.Profit loss before tax IFRS
Net income (owners)¥7.9bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.6bn2022-04-01 → 2022-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥15.9bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥10.6bn2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥5.2bn2021-04-01 → 2021-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥7.9bn2022-01-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥4.6bn2022-04-01 → 2022-06-30dCons.Profit loss IFRS
Net income¥10.6bn2021-01-01 → 2021-06-30Cons.Profit loss IFRS
Net income¥5.2bn2021-04-01 → 2021-06-30dCons.Profit loss IFRS
Total assets¥228.6bnat 2022-06-30Cons.Assets IFRS
Total assets¥209.3bnat 2021-12-31Cons.Assets IFRS
Total assets¥207.6bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥116.7bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥111.0bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥111.8bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥98.3bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥94.1bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥81.9bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥111.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥98.3bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥94.1bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥45.0bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥42.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥31.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Operating cash flow¥3.4bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥18.8bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥9.1bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥6.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥3.2bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥1.0bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥2.6bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥838m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥158.622022-01-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥92.762022-04-01 → 2022-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥318.352021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥2132021-01-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥104.092021-04-01 → 2021-06-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥317.162021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥211.42021-01-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio48.9%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio47.0%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.4%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-06-30−¥446m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥212m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥400m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥152m
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2022-01-01 → 2022-06-30¥3.7bn
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.3bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2022-01-01 → 2022-06-30¥3.4bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2022-01-01 → 2022-06-30¥0
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2022-04-01 → 2022-06-30−¥6m
—segment totalsegment profit2022-01-01 → 2022-06-30¥7.1bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥3.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-01-01 → 2021-06-30−¥538m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥205m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-06-30−¥474m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥774m
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2021-01-01 → 2021-06-30¥8.6bn
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2021-04-01 → 2021-06-30¥4.7bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2021-01-01 → 2021-06-30¥2.8bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.6bn
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2021-01-01 → 2021-06-30¥487m
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2021-04-01 → 2021-06-30¥209m
—segment totalsegment profit2021-01-01 → 2021-06-30¥11.9bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥6.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-06-30¥11.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥6.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 942
ItemContextValueUnit
Finance costs IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Finance costs IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Finance costs IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Finance costs IFRSPrior1YTDDuration509000000JPY
Profit loss before tax IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember-JPY
Profit loss before tax IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember-JPY
Profit loss before tax IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember-JPY
Profit loss before tax IFRSPrior1YTDDuration_ReportableSegmentsMember-JPY
Profit loss before tax IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Profit loss before tax IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Profit loss before tax IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Profit loss before tax IFRSPrior1YTDDuration12238000000JPY
Sales to external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember36169000000JPY
Sales to external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember33590000000JPY
Sales to external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember14610000000JPY
Sales to external customers IFRSCurrentYTDDuration_ReportableSegmentsMember84371000000JPY
Sales to external customers IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember3846000000JPY
Sales to external customers IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember88217000000JPY
Sales to external customers IFRSCurrentYTDDuration_ReconcilingItemsMember-JPY
Sales to external customers IFRSCurrentYTDDuration88217000000JPY
Intersegment sales IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember108000000JPY
Intersegment sales IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember5000000JPY
Intersegment sales IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember-JPY
Intersegment sales IFRSCurrentYTDDuration_ReportableSegmentsMember114000000JPY
Intersegment sales IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember498000000JPY
Intersegment sales IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember612000000JPY
Intersegment sales IFRSCurrentYTDDuration_ReconcilingItemsMember-612000000JPY
Intersegment sales IFRSCurrentYTDDuration-JPY
Net sales IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember36278000000JPY
Net sales IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember33595000000JPY
Net sales IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember14610000000JPY
Net sales IFRSCurrentYTDDuration_ReportableSegmentsMember84485000000JPY
Net sales IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4344000000JPY
Net sales IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember88829000000JPY
Net sales IFRSCurrentYTDDuration_ReconcilingItemsMember-612000000JPY
Net sales IFRSCurrentYTDDuration88217000000JPY
Operating profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember3393000000JPY
Operating profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember3720000000JPY
Operating profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember0JPY
Operating profit loss IFRSCurrentYTDDuration_ReportableSegmentsMember7114000000JPY
Operating profit loss IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-446000000JPY
Operating profit loss IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember6668000000JPY
Operating profit loss IFRSCurrentYTDDuration_ReconcilingItemsMember-400000000JPY
Operating profit loss IFRSCurrentYTDDuration6267000000JPY
Finance income IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember-JPY
Finance income IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember-JPY
Finance income IFRSCurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember-JPY
Finance income IFRSCurrentYTDDuration_ReportableSegmentsMember-JPY
Finance income IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Finance income IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass